Fagron’s strategy is focused on optimizing and innovating customized pharmaceutical care in order to widen the therapeutic options of prescribers worldwide. As the leading global company in pharmaceutical compounding, we are supporting the unique selling point of customized medication and improving patients’ quality of life.
As the leading company in pharmaceutical compounding, Fagron develops innovative concepts and solutions that respond to the specific and individual wishes of compounding pharmacies all over the world. In Fagron’s Innovation department, over 200 pharmacists are dedicated to developing and providing innovative concepts, products and formulas that will meet the demands of the pharmacist, prescriber and patient.

Type
Public
HQ
Rotterdam, NL
Founded
1990
Size (employees)
2,106 (est)-9%
Website
fagron.com
Fagron was founded in 1990 and is headquartered in Rotterdam, NL
Report incorrect company information

Key People/Management at Fagron

Rafael Padilla

Rafael Padilla

CEO
Karin de Jong

Karin de Jong

CFO
Constantijn van Rietschoten

Constantijn van Rietschoten

Chief Communications Officer
Show more

Fagron Office Locations

Fagron has an office in Rotterdam
Rotterdam, NL (HQ)
182 Lichtenauerlaan
Show all (1)
Report incorrect company information

Fagron Online and Social Media Presence

Embed Graph
Report incorrect company information

Fagron News and Updates

Fagron, Inc. Announces New Hair Care Line - TrichoConcept™

ST. PAUL, Minn., Aug. 7, 2018 /PRNewswire/ -- Fagron, Inc. (Fagron) introduces TrichoConcept™, the first global line of multifunctional vehicles available in the United States with patented TrichoTech™ technology, an intelligent phytocomplex, that balances the entire hair system – bulb,...

Nuvo Pharmaceuticals™(Ireland) Limited Enters into Resultz® License and Supply Agreement with Fagron Belgium NV for Belgium, the Netherlands and Luxembourg

MISSISSAUGA, ON, July 23, 2018 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX: NRI; OTCQX: NRIFF), a commercial healthcare company with a portfolio of marketed products and pharmaceutical manufacturing capabilities, today announced that its wholly owned subsidiary,...

Fagron Sterile Services Issues Voluntary Nationwide Recall of Neostigmine Methylsulfate 1mg/mL, 5mg per 5mL and Neostigmine Methylsulfate 1mg/mL, 3mg per 3mL, in a 5mL Syringe Due to Mislabeling

WICHITA, Kan., June 29, 2018 /PRNewswire/ -- Fagron Sterile Services is voluntarily recalling two (2) lots of Neostigmine Methylsulfate 5mL syringes to the user/hospital/clinic level. The specified product lots are being recalled because of a confirmed custome...

Fagron Sterile Services Issues Voluntary Nationwide Recall of Neostigmine Methylsulfate 1mg/mL, 5mg per 5mL and Neostigmine Methylsulfate 1mg/mL, 3mg per 3mL, in a 5mL Syringe Due to Mislabeling

WICHITA, Kan., June 29, 2018 /PRNewswire/ -- Fagron Sterile Services is voluntarily recalling two (2) lots of Neostigmine Methylsulfate 5mL syringes to the user/hospital/clinic level. The specified product lots are being recalled because of a confirmed custome...

Fagron Sterile Services Issues Voluntary Nationwide Recall of Neostigmine Methylsulfate 1mg/mL, 5mg per 5mL and Neostigmine Methylsulfate 1mg/mL, 3mg per 3mL, in a 5mL Syringe Due to Mislabeling

WICHITA, Kan., June 29, 2018 /PRNewswire/ -- Fagron Sterile Services is voluntarily recalling two (2) lots of Neostigmine Methylsulfate 5mL syringes to the user/hospital/clinic level. The specified product lots are being recalled because of a confirmed custome...
Show more
Report incorrect company information

Fagron Company Life and Culture

Report incorrect company information